Asset Dedication, LLC Alaunos Therapeutics, Inc. Transaction History

Asset Dedication, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 18, 2021	BUY	$1.44 - $2.73 $10,080 - $19,110	7,000 Added 552.92%	8,266 $15,000
Q2 2021 Jul 21, 2021	BUY	$2.63 - $3.67 $3,329 - $4,646	1,266 New	1,266 $3,000
Q2 2018 Aug 13, 2018	SELL	$3.02 - $4.94 $347 - $568	-115 Closed	0 $0
Q1 2018 Apr 19, 2018	BUY	$3.46 - $5.14 $397 - $591	115 New	115 $0

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Asset Dedication, LLC, based on Form 13F filings with the SEC.

Stay updated on Asset Dedication, LLC with notifications on news.